Astex Pharmaceuticals to Present at ROTH Conference

| Source: Astex Pharmaceuticals, Inc.

DUBLIN, Calif., March 12, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics, today announced that James S.J. Manuso, PhD, chairman and chief executive officer, will present at the 25th Annual ROTH Conference on Tuesday March 19th in Laguna Niguel, California.

The Company's presentation will begin at 3:30 p.m. PT. A live webcast of the presentation will be available in the Investor Events section of the Company's website, The webcast will be archived for 30 days.

About Astex Pharmaceuticals

Astex Pharmaceuticals is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology. The Company is developing a proprietary pipeline of novel therapies and is creating de-risked products for partnership with leading pharmaceutical companies. Astex Pharmaceuticals developed DACOGEN® (decitabine) for Injection and receives significant royalties on global sales.

The Astex Pharmaceuticals, Inc. logo is available at

For more information about Astex Pharmaceuticals, Inc., please visit

Timothy L. Enns
Astex Pharmaceuticals, Inc.
Senior Vice President
Corporate Communications & Marketing
Tel:  +1 (925) 560-2810

Susanna Chau
Astex Pharmaceuticals, Inc.
Investor Relations
Tel:  +1 (925) 560-2845

Alan Roemer
The Trout Group
Managing Director
Tel:  +1 (646) 378-2945